null

FITC Anti-Human CD37 Antibody [IPO-24] (AGEL1017)

SKU:
AGEL1017
Product Type:
Antibody
Antibody Type:
Monoclonal Antibody
Reactivity:
Human
Applications:
FC
€189 - €629
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

FITC Anti-Human CD37 Antibody [IPO-24]

The Human CD37 Monoclonal Antibody FITC-conjugated (IPO-24) is a specialized tool for researchers studying CD37, a protein found on the surface of human cells that plays a key role in immune system function. This monoclonal antibody, conjugated with FITC for fluorescence detection, is produced for use in various immunological research applications.CD37 is a transmembrane glycoprotein known to be involved in B-cell signaling and activation, making it a vital target for investigations in immunology and cancer biology. By specifically binding to CD37, this antibody allows for precise identification and analysis of CD37-expressing cells in diverse experimental settings.

Its FITC conjugation enhances visualization and tracking of CD37-positive cells, enabling detailed studies on their behavior and function.Researchers exploring immune cell interactions, signal transduction pathways, and disease mechanisms rely on tools like the Human CD37 Monoclonal Antibody FITC-conjugated (IPO-24) to advance their understanding of immune responses and develop potential therapeutic strategies. With its proven specificity and versatility, this antibody is a valuable asset for uncovering the intricacies of CD37 biology and its implications in health and disease.